January 26, 2023
Dr. Jeffrey Kiel, founder and CEO of Kiel Laboratories, talks about offshore outsourcing in the USA and working with Quinta-Analytica.
January 5, 2023
Pharma innovators often outsource demanding projects to specialist CROs. Gus Bassani of US-based PCCA and Markus Dachtler of Conscio's German subsidiary Gen-Plus, share lessons from their collaboration.
December 7, 2022
We at Quinta-Analytica are proud to announce the successful completion of not 1 but 2 FDA inspections at our Prague and Brno sites. Thanks for your trust and support!
November 24, 2022
Quinta-Analytica's 25th Anniversary give us the chance to look back at our successful trajectory of proactiveness, technical expertise and improvement in the company of Dr Miroslav Ryska, mass spectrometry expert and founder of Quinta.
November 16, 2022
Interested in clinical study design? Today's Clinical Tips series focuses on intra- and inter-subject variability, crucial concepts for the correct calculation of sample size.
October 30, 2022
Quinta-Analytica is attending CPHI 2022 in Frankfurt
October 13, 2022
Are you a pharma company in need of stability testing but have just too many candidates to screen with conventional ICH assays? We at Quinta-Analytica can offer you accurate stability data 3 times faster than usual! Find out more below.
September 8, 2022
Quinta-Analytica is among the few CROs offering GCP/GLP/GMP services for biologics. We and our valued biotech client SOTIO wish to share our experience with antibody-drug conjugates, the toughest biologics.
August 30, 2022
QUINTA is well-known for its state-of-the-art equipment and facilities used to perform clinical trials and bioanalytical services under GCP/GLP; but today our experts wish to talk about pharmacokinetics and statistical evaluations, an important part of their day to day work which doesn't always get the attention it deserves. Click and keep reading!
August 11, 2022
Today we proudly announce that Gen-Plus GmbH & Co. KG, a Munich-based pharma R&D and manufacturing expert, has become a new member of the Conscio Group.
July 28, 2022
We are proud to announce that Quinta-Analytica has donated 100,000 CZK to the Olga Havel Foundation for the support of six families with members in need of neurorehabilitation.
June 22, 2022
Have you heard about Nitrosamine Analogues? Did you know even if a tested API is free of nitrosamine analogues, its related drug product may still contain high amounts of these new impurities? Keep reading to learn more!
May 26, 2022
Volunteers participating in trials at our clinical unit are sometimes surprised to discover that samples collected during the studies are not always blood but can also involve other biological fluids such as urine. Keep reading to learn more about our clinical R&D activities.
May 12, 2022
The introduction of Ultra-High Performance Liquid Chromatography was a significant milestone in the evolution of LC, and is certainly a very powerful tool for today’s chromatographer
May 4, 2022
The bioequivalence of generic versions of certain reference drugs can often be complicated by the presence of endogenous levels of compounds, so how can you identify them?
April 21, 2022
Prior to the release of a #pharmaceutical, it has always been necessary to determine the impurity profile of the final product, however nowadays the impurities from the components used during manufacture and storage must be also considered.
April 7, 2022
Ви українець та шукаєте роботу в Чехії? | Are you Ukrainian and looking for work in the Czech Republic? | Jste z Ukrajiny a hledáte práci v České republice?
March 24, 2022
The design of pharmacokinetic sampling times plays a critical role in the reliability of bioequivalence evaluation, as does ensuring that enough samples are collected.
March 10, 2022
Cancer biologists at a world-renowned university have developed a new piece of technology that will help researchers see cells in more precise detail
February 24, 2022
Deaths caused by infectious diseases have fallen by 70% since antibiotics were introduced on a large scale in the 1940s, yet we’ve seen a significant decrease in the number of new antibiotics reaching the market and this could be an issue.
February 10, 2022
Finally, for the first time, information about all veterinary medicines authorized in the EU and European Economic Area (EEA) countries will be available on a central website.
January 27, 2022
Flagged as the next generation of ultra-performance instrumentation, the high resolution of the quaternary LC System offers a significant improvement when compared to older models.
January 20, 2022
The European Commission, HMA, and EMA have launched an initiative to transform how clinical trials are run across the union.
January 13, 2022
The measurement of drug concentrations in biological matrices is an important aspect of medicinal product development.
January 6, 2022
This key branch of pharmacology is dedicated to determining the fate of substances administered to a living organism, such as pharmaceutical drugs, pesticides, and food additives.
December 20, 2021
As the Holiday Season is upon us, we find ourselves reflecting on the past year, and what a rollercoaster it has been!
December 16, 2021
Real-world data and real-world evidence are already used in the regulation of some medicines across the EU, but the vision is that by 2025 the use of RWE will have been fully enabled.
December 9, 2021
When we look back at the people that kept the world turning during these difficult times, we pay our thanks to those who continued to enable drug development and safely help bring drugs to market in the quickest possible way.
December 2, 2021
QUINTA-ANALYTICA are very happy to announce new investment from renowned family equity firm BBA CapitalPartners.
November 25, 2021
With the world waking up to the effects of climate change, QUINTA-ANALYTICA have taken their own first small step this week in giving back, one tree at a time.
November 18, 2021
With Artificial Intelligence penetrating the pharma world at a rapid pace, three regulators have joined forces with the aim of fostering Good Machine Learning Practice (GMLP).
November 10, 2021
Following a thrilling first day in milano at the fieramilano exhibition space, CPhI gets underway for day two and the QUINTA-ANALYTICA team are fired up and raring to go.
November 9, 2021
As CPhI Worldwide gets underway, the QUINTA-ANALYTICA team are all set up here in milan and ready to welcome you.
November 4, 2021
Billed as the biggest pharma event of the year, CPhI 2021 is a prime opportunity to make new connections and meet the QUINTA-ANALYTICA team.
October 28, 2021
HVD are drugs whose within-subject variance is larger than preset regulatory bioequivalence limits. How do we properly measure and test these types of drugs?
October 21, 2021
Narrow therapeutic index (NTI) drugs are defined as those drugs where small differences in dose, or concentration in the blood, may lead to serious therapeutic failures or adverse drug reactions.
October 14, 2021
We all love to eat, but many people are unaware of the correlation between food and medicine effectiveness.
October 6, 2021
As many of us struggle to believe it’s October already, the realization of that calendar milestone also means we’re just one month away from the biggest pharma event of the year, CPhI Worldwide.
September 30, 2021
It may be the Czech Republics’ second-largest city, but there’s nothing second about the knowledge and long-term experience of dissolution testing brought to the city by its new pharma resident, QUINTA-ANALYTICA.
September 23, 2021
Bioequivalence and bioavailability studies should be conducted preferentially from a healthy volunteer population unless the drug carries safety concerns that make this unethical.
September 15, 2021
In keeping with the annual tradition of celebrating the wind down from summer, the teams at QUINTA-ANALYTICA certainly let their hair down in style last Friday.
September 9, 2021
Quinta are enormously proud to announce the opening of their new, USA-based affiliate company, Conscio Pharmaceuticals Inc.
September 2, 2021
Administration of medication requires a thorough understanding of how and when it moves through the body, possible side effects or reactions, and the correct way to deliver it.
August 26, 2021
It’s not always easy to manage the array of dietary requirements, veterinary needs, and overall health of your furry, fluffy, or indeed scaly companions.
August 18, 2021
As the prevalence of mRNA vaccines starts to take a solid foothold and their development rapidly into other medicinal areas hits new heights, finding the right pharma services company has become ever more a challenge.
August 12, 2021
Whatever size your firm, it's essential to deliver on client expectations.
August 5, 2021
Before taking the plunge and carrying out a full-scale bioequivalence trial, it is typically desirable to dip your toe in the water, and often makes a lot of business sense, to first conduct a pilot trial.
July 28, 2021
The information that has been unlocked is vast, and indeed is being hailed as one of the most important datasets since the mapping of the Human Genome.
July 21, 2021
Soon to become the single entry point for submitting clinical trial information in the EU, we present the Clinical Trial Information System (CTIS).
July 15, 2021
Are small and medium enterprises (SME’s) really a major driver of innovation in the pharmaceutical industry?
July 7, 2021
It's clear to see the continued dominance of the Nitrosamines topic, and the impact the stringent rules and regulations are having on the industry.
July 1, 2021
Nothing short of complex, and requiring highly intricate detail to conduct, the assessment of bioequivalence is a critical component in getting any new drugs to market.
June 28, 2021
This week sees the pharma industry get together virtually once more as the CPhI Conferences Nitrosamine Impurities Forum 2021 gets underway.
June 23, 2021
Before a new medicine or biologic can be marketed, its sponsor must show, through adequate and well-controlled clinical experiments, that it is effective.
June 17, 2021
As everyone in the pharma world knows, stability testing is one of the most crucial steps in the development of new drug products.
June 10, 2021
Across the pharma world, the alignment to guidelines and rules set out by the regulatory authorities must be not only met but exceeded in order to deliver success.
June 3, 2021
This week we celebrated our teams, getting back to normal, and the arrival of summer.
May 27, 2021
World-leading companies such as QUINTA-ANALYTICA are embracing new technologies critical to revolutionizing research, attracting patients for trials, and reducing the speed of delivering results.
May 24, 2021
Quinta has received EU funding toward the construction of it's new research and development laboratory in Brno, Czech Republic.
May 19, 2021
Crossover trials are clinical experiments in which participants are randomly assigned to a sequence of treatments wherein each participant serves as their own control in estimating effects.
May 13, 2021
As an employer of hundreds of professionals, QUINTA-ANALYTICA takes staff engagement, motivation, and culture incredibly seriously.
May 6, 2021
The team are pleased to announce delivery of our latest innovative piece of technology, allowing us to offer even greater selectivity and sensitivity to our clients and partners.
April 28, 2021
EcoVadis is the world’s most trusted provider of business sustainability ratings, and their sustainability scorecard ranked Quinta amongst the top companies assessed.
April 22, 2021
Quinta-Analytica's facilities in our HQ in Prague and also at our newest lab in Brno passes the latest GMP inspection by the Czech State Institute for Drug Control, SUKL.
April 15, 2021
If you’re developing volatile compounds, struggling with in-vitro testing, or looking for someone who has Franz diffusion cell expertise for your permeation studies, look no further.
April 8, 2021
A generic drug contains the same chemical substance as a drug that was originally branded and protected by patents (now expired).
April 1, 2021
Although an ocean may divide them, when it comes to choosing the right pharma services company, distance knows no bounds.
March 25, 2021
Offering a full range of clinical pharmacology solutions, bioavailability, interaction, bioequivalence, and much more, our purpose-built clinic allows for a huge range of trials.
March 17, 2021
The repositioning of existing drugs could be one of the keys to quickly seek effective drugs to reduce mortality and morbidity.
March 10, 2021
An essential part of QUINTA-ANALYTICA’s service portfolio, its BioPharma team offers comprehensive support.
March 4, 2021
The world moves forward, and so do we. Introducing our new look website.
February 25, 2021
Quality Control project management is an independent and essential function within the analytical operations department.
February 18, 2021
Offering extensive experience in the field of bioequivalence studies from project design and documentation, through clinical and bioanalytical work complete with full statistical clinical reports.
February 11, 2021
Working both with methods provided by customers and those developed by our Analytical R&D teams, we offer a very flexible approach to meet your needs and be your true pharma partner.
February 4, 2021
Offering a comprehensive range of services including testing of the application form of drugs to guarantee compliance with exact specifications, our Bioanalytical laboratory is here to support all analytical aspects of your clinical and pre-clinical tests.
January 27, 2021
Viscosity is a principal parameter when any flow measurements of fluids, such as liquids, semi-solids, gases, and even solids are made.
January 19, 2021
The world is fast running out of effective antibiotics as bacteria evolve to develop resistance to our taken-for-granted treatments.
January 12, 2021
This presentation by the European Medicines Agency on Covid-19 drug testing monitoring.
January 7, 2021
Our API Solutions truly remove complexity and bring true value to your developmental process.
December 28, 2020
Offering a comprehensive end-to-end service in collaboration with a strategic partner, QUINTA-ANALYTICA can offer everything from preclinical development to toxicological (TK) studies.
December 21, 2020
Wishing our clients, colleagues, and friends all the very best for a healthy, prosperous, and exciting 2021!
December 17, 2020
Offering incredible accuracy and lightning-fast results, there is no better way to verify the identity of precursor materials used in the preparation of your drugdevelopment.
December 9, 2020
We are exceptionally proud to welcome to our team, starting January, our new Head of Quality Assurance, Dr. Miroslav Janousek!
December 2, 2020
We are excited and very proud to welcome Dr. Ondrej Palan to the Quinta team!
November 26, 2020
Stay safe and celebrate this holiday season in good health!
November 19, 2020
Regardless of the study phase, magnitude of the trial, dosage forms, or trial design, getting your packaging and labeling right is critical.
November 12, 2020
Electrochemiluminescence is a highly successful detection system that achieves clinical quality data in a variety of sample types.
November 5, 2020
The free-of-charge event strives to get the widest audience possible from health and medicines R&D together.
October 29, 2020
With Brexit looming and the UK PM Boris Johnson saying last week that we must prepare for 'no deal', the pharma industry is on tenterhooks.
October 23, 2020
The pharmaceutical industry is seeing a shift toward personalized medicines, and it’s evolving to deliver this via some exciting new tools.
October 16, 2020
Starting October 19th developers of human or veterinary medicines are instructed to use the EMA's new platform to request scientific advice.
October 9, 2020
It should be a given fact for an industry so important to the world as pharmaceutical, but it’s still reassuring to see it announced publicly.
September 29, 2020
With some of the best chemists in the industry using state of the art science and lab techniques, it now really is possible to identify the unidentified!
September 22, 2020
Here’s what you need to know from the FDA’s updated guidance for clinical trials during the pandemic.
September 17, 2020
The Royal Society of Chemistry has announced that its full collection of research journals are now available.
September 9, 2020
If your drug has been suspended, get in touch to see how we can help.
September 2, 2020
Working with key research projects Quinta are proud to be doing their part in the collective effort to rid the world of the most impactful issue ever seen.
August 27, 2020
Quinta have been granted approval into the French Tax Credit system.
August 17, 2020
We’ll be attending the “Nitrosamines Impurities Forum (Americas)” next week. Will you join us?
August 11, 2020
The European Medicines Agency just announced yet another extension for the testing of Nitrosamines contamination.